UK markets open in 5 hours 8 minutes

Akebia Therapeutics, Inc. (AKBA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2600-0.0600 (-4.55%)
At close: 04:00PM EDT
1.2400 -0.02 (-1.59%)
After hours: 07:58PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
194,623
194,623
292,484
211,650
294,644
Cost of revenue
74,149
74,149
85,568
150,671
296,477
Gross profit
120,474
120,474
206,916
60,979
-1,833
Operating expenses
Research development
63,079
63,079
129,986
147,852
218,485
Selling general and administrative
100,233
100,233
138,601
174,140
154,099
Total operating expenses
166,549
166,549
271,762
325,481
375,993
Operating income or loss
-46,075
-46,075
-64,846
-264,502
-377,826
Interest expense
6,032
6,032
15,687
19,936
8,871
Total other income/expenses net
182
182
-13,693
2,414
1,856
Income before tax
-51,925
-51,925
-94,226
-282,024
-384,841
Income tax expense
-
-
0
0
0
Income from continuing operations
-51,925
-51,925
-94,226
-282,024
-384,841
Net income
-51,925
-51,925
-94,226
-282,024
-384,841
Net income available to common shareholders
-51,925
-51,925
-94,226
-282,024
-384,841
Basic EPS
-0.31
-
-0.52
-1.70
-2.78
Diluted EPS
-0.31
-
-0.52
-1.70
-2.78
Basic average shares
185,984
-
182,783
165,950
138,463
Diluted average shares
185,984
-
182,783
165,950
138,463